These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 35993712)

  • 1. Hepatitis B Virus-Encoded HBsAg Contributes to Hepatocarcinogenesis by Inducing the Oncogenic Long Noncoding RNA LINC00665 through the NF-κB Pathway.
    Ahluwalia S; Ahmad B; Salim U; Ghosh D; Kamuju V; Ghosh A; Dabeer K; Menon MB; Vivekanandan P
    Microbiol Spectr; 2022 Oct; 10(5):e0273121. PubMed ID: 35993712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation-Induced Long Intergenic Noncoding RNA (LINC00665) Increases Malignancy Through Activating the Double-Stranded RNA-Activated Protein Kinase/Nuclear Factor Kappa B Pathway in Hepatocellular Carcinoma.
    Ding J; Zhao J; Huan L; Liu Y; Qiao Y; Wang Z; Chen Z; Huang S; Zhao Y; He X
    Hepatology; 2020 Nov; 72(5):1666-1681. PubMed ID: 32083756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9-mediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV-positive hepatocellular carcinoma cells.
    Song J; Zhang X; Ge Q; Yuan C; Chu L; Liang HF; Liao Z; Liu Q; Zhang Z; Zhang B
    J Cell Biochem; 2018 Nov; 119(10):8419-8431. PubMed ID: 29904948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response.
    Sunami Y; Ringelhan M; Kokai E; Lu M; O'Connor T; Lorentzen A; Weber A; Rodewald AK; Müllhaupt B; Terracciano L; Gul S; Wissel S; Leithäuser F; Krappmann D; Riedl P; Hartmann D; Schirmbeck R; Strnad P; Hüser N; Kleeff J; Friess H; Schmid RM; Geisler F; Wirth T; Heikenwalder M
    Hepatology; 2016 May; 63(5):1592-607. PubMed ID: 26892811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
    Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
    J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA TFAP2A-AS1 Suppressed Hepatitis B Virus Replication by Modulating miR-933/HDAC11.
    Cheng Y; Shi W; Cui X; Sun L; Nan Y; Yao H; Fan J; Zhu L; Yu L
    Dis Markers; 2022; 2022():7733390. PubMed ID: 35478990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA PCNAP1 modulates hepatitis B virus replication and enhances tumor growth of liver cancer.
    Feng J; Yang G; Liu Y; Gao Y; Zhao M; Bu Y; Yuan H; Yuan Y; Yun H; Sun M; Gao H; Zhang S; Liu Z; Yin M; Song X; Miao Z; Lin Z; Zhang X
    Theranostics; 2019; 9(18):5227-5245. PubMed ID: 31410212
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis B Virus Small Envelope Protein Promotes Hepatocellular Carcinoma Angiogenesis via Endoplasmic Reticulum Stress Signaling To Upregulate the Expression of Vascular Endothelial Growth Factor A.
    Wu SX; Ye SS; Hong YX; Chen Y; Wang B; Lin XJ; Lin X
    J Virol; 2022 Feb; 96(4):e0197521. PubMed ID: 34910612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic hepatitis B virus large surface antigen induces hepatocyte hyperploidy via failure of cytokinesis.
    Li TN; Wu YJ; Tsai HW; Sun CP; Wu YH; Wu HL; Pei YN; Lu KY; Yen TT; Chang CW; Chan HL; Tao MH; Liou JY; Chang MD; Su IJ; Wang LH
    J Pathol; 2018 Aug; 245(4):502-513. PubMed ID: 29862509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B Surface Antigen Promotes the Invasion of Hepatitis B Virus-Related Hepatocellular Carcinoma Cells by Upregulation of Toll-Like Receptor 2.
    Cheng S; Zhang B; Du JY; Jin YH; Lang HY; Zeng LH
    Viral Immunol; 2017 Apr; 30(3):232-239. PubMed ID: 28061318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP1B3 cooperates with BST-2 to promote hepatitis B virus restriction.
    Zheng B; Zhang J; Zheng T; Wang H; Li Z; Huan C; Ning S; Wang Y; Zhang W
    J Med Virol; 2020 Feb; 92(2):201-209. PubMed ID: 31556466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBx-induced MiR-1269b in NF-κB dependent manner upregulates cell division cycle 40 homolog (CDC40) to promote proliferation and migration in hepatoma cells.
    Kong XX; Lv YR; Shao LP; Nong XY; Zhang GL; Zhang Y; Fan HX; Liu M; Li X; Tang H
    J Transl Med; 2016 Jun; 14(1):189. PubMed ID: 27349221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
    Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma.
    Huang JL; Ren TY; Cao SW; Zheng SH; Hu XM; Hu YW; Lin L; Chen J; Zheng L; Wang Q
    Oncotarget; 2015 Oct; 6(32):33791-804. PubMed ID: 26393879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction.
    Zheng Y; Ming P; Zhu C; Si Y; Xu S; Chen A; Wang J; Zhang B
    J Biol Chem; 2019 Mar; 294(13):4815-4827. PubMed ID: 30659097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro.
    Salpini R; Surdo M; Warner N; Cortese MF; Colledge D; Soppe S; Bellocchi MC; Armenia D; Carioti L; Continenza F; Di Carlo D; Saccomandi P; Mirabelli C; Pollicita M; Longo R; Romano S; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Iapadre N; Barlattani A; Bertoli A; Mari T; Pasquazzi C; Missale G; Sarrecchia C; Orecchini E; Michienzi A; Andreoni M; Francioso S; Angelico M; Verheyen J; Ceccherini-Silberstein F; Locarnini S; Perno CF; Svicher V
    Oncotarget; 2017 Feb; 8(9):15704-15715. PubMed ID: 28152517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined identification of three lncRNAs in serum as effective diagnostic and prognostic biomarkers for hepatitis B virus-related hepatocellular carcinoma.
    Fu P; Gong B; Li H; Luo Q; Huang Z; Shan R; Li J; Yan S
    Int J Cancer; 2022 Nov; 151(10):1824-1834. PubMed ID: 35802466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA NKILA inhibits HBV replication by repressing NF-κB signalling activation.
    Zhang X; Li Y; Huan C; Hou Y; Liu R; Shi H; Zhang P; Zheng B; Wang Y; Wang H; Zhang W
    Virol Sin; 2024 Feb; 39(1):44-55. PubMed ID: 37832719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2.
    Fan H; Zhang H; Pascuzzi PE; Andrisani O
    Oncogene; 2016 Feb; 35(6):715-26. PubMed ID: 25893293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HBsAg/β2GPI activates the NF‑κB pathway via the TLR4/MyD88/IκBα axis in hepatocellular carcinoma.
    Jing X; Tian Z; Gao P; Xiao H; Qi X; Yu Y; Ding X; Yang L; Zong L
    Oncol Rep; 2018 Aug; 40(2):1035-1045. PubMed ID: 29916535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.